Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.
Dow Jones Newswires
Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:BEAM
- Language
- English (India)